GCKR and GCK polymorphisms are associated with increased risk of end-stage kidney disease in Chinese patients with type 2 diabetes: The Hong Kong Diabetes Register (1995-2019) - Wang, K; Shi, M; Yang, A (Diabetes Res Clin Pract, 2022)